Purpose: To elucidate relationship of total cholesterol (TC) level to results of follow-up of patients (pts) with systolic chronic heart failure (CHF).
Methods: In a framework of various international and local trials we prospectively followed up 130 patients (pts) with stable NYHA class II-IV HF and ejection fraction (EF) 40% or less. Criterion of inclusion in this analysis was presence of TC value obtained at baseline examination for a given trial. Mean age of pts was 65 +/- 9 years, 78% were men. During follow-up (mean 1.3 +/- 0.8, median 1.4 years) we registered all deaths and hospitalizations for heart failure worsening.
Results: During follow up 31 pts died and 38 were hospitalized. Compared to the group of pts without these events, pts who died had higher baseline fasting glucose (7.8 +/- 3.6 vs. 6.7 +/- 2.1 mmol/L; p=0.026) and lower TC (5.09 +/- 1.57 vs. 5.50 +/- 1.31 mmol/L; p=0.052) levels. Compared to event-free group, those who were hospitalized had significantly lower hemoglobin (Hb) (135 +/- 17 vs. 143 +/- 15 g/L; p=0.010). Cox proportionate hazards model included age, sex, EF, NYHA class, BMI, hemoglobin, glucose, creatinine, TC, history of hypertension, smoking, presence of disturbances of cardiac rhythm and conduction, medications. Mortality risk correlated with glucose and TC levels; each 1-mmol/L increase in glucose concentration was associated with 17% increase of mortality risk [hazard ratio (HR) 1.17; 95% confidence interval (CI) 1.05 to 1.31, p=0.005], and each 1-mmol/L decrease in TC - with 26% increase of mortality risk (HR 0.74, 95%CI 0.55 to 1.00, p=0.052). Left bundle branch block (LBBB) was an independent predictor of mortality (HR 2.51, 95%CI 1.02 to 6.18, p=0.045). Heart failure hospitalizations were linked to hemoglobin level and NYHA class. Each 10-g/L decrease in hemoglobin was associated with 31% elevation of risk of hospitalization (HR 0.69, 95%CI 0.51 to 0.92, p=0.011). There was almost 5-fold difference in risk of hospitalization between NYHA class II and IV (HR 4.80, 95%CI 2.64 to 8.73, p < 0.001). Pts with glucose > 7.4 mmol/L, or TC < 4.0 mmol/L, or hemoglobin < 130 g/L (optimal specificity/sensitivity derived from ROC curves) were at higher risk of an event. Kaplan-Meier survival analysis revealed that pts with glucose > 7.4 mmol/L, TC < 4.0 mmol/L, hemoglobin < 130 g/L had significantly reduced survival: p=0.050, p=0.006, p=0.016, respectively.
Conclusion: In a homogeneous group of pts with chronic heart failure and low EF characterized by usual relationships between established factors of prognosis (NYHA class, hemoglobin, LBBB) and development of events lower TC and higher glucose levels were each associated with worse outcome.
Download full-text PDF |
Source |
---|
J Clin Med
January 2025
Universidad Simón Bolívar, Facultad de Ciencias de la Salud, Centro de Investigaciones en Ciencias de la Vida, Barranquilla 080001, Colombia.
Several parameters have been proposed for the objective measurement of the quality of care (QoC) and breaches of care in patients with heart failure (HF). Therefore, the objective of this study was to evaluate the measures of QoC in inpatients with decompensated HF in the cardiology department of a tertiary Venezuelan hospital. : An observational, descriptive, ambispective study was conducted with adults of all genders diagnosed with decompensated HF between 2022 and 2024.
View Article and Find Full Text PDFBiomedicines
January 2025
Clinic for Cardiology, Military Medical Academy, 11000 Belgrade, Serbia.
: It is unknown how early exercise therapy combined with acupuncture (AP) affects the speed of recovery in patients suffering from heart failure with reduced ejection fraction (HFrEF) who are hospitalized due to worsening HF. : A prospective, sham-procedure-controlled, double-blind, randomized clinical trial with three patient groups was conducted. The study included patients with HFrEF who were hospitalized for worsening HF.
View Article and Find Full Text PDFAm J Cardiol
January 2025
Department of Cardiovascular Medicine, Baystate Medical Center and Division of Cardiovascular Medicine, University of Massachusetts-Baystate, Springfield, Massachusetts, USA. Electronic address: https://twitter.com/AGoldsweig.
Introduction: Obstructive hypertrophic cardiomyopathy (oHCM) is a genetic disorder characterized by myocardial hypertrophy, which can obstruct left ventricular outflow. Cardiac myosin inhibitors (CMIs) have emerged as a novel therapeutic agent targeting cardiac muscle hypercontractility.
Objective: To compare the efficacy and safety of CMIs mavacamten and aficamten vs.
J Cardiovasc Dev Dis
January 2025
Department of Cardiology, University Hospital Galway, Saolta University Healthcare Group, Newcastle Road, H91YR71 Galway, Ireland.
Hospitalisation for acute decompensated heart failure (HF) portends a poor prognosis. Fluid retention manifesting in dyspnoea and oedema are important clinical features of decompensated heart failure and drive hospital admissions. Intracardiac and pulmonary artery pressure (PAP) monitoring can help predict heart failure decompensation, as changes in these haemodynamics occur before clinical congestion manifests.
View Article and Find Full Text PDFJ Cardiovasc Dev Dis
December 2024
2nd Cardiology Department, Interbalkan Medical Center, 55535 Thessaloniki, Greece.
Background: Mitral regurgitation (MR) is a common valvular disorder linked to high morbidity and mortality. For patients unsuitable for surgery, transcatheter mitral edge-to-edge repair (TEER) with the MitraClip G4 system offers an alternative. This study aims to evaluate procedural, echocardiographic, functional, and quality of life (QoL) outcomes in patients who underwent TEER with the MitraClip G4 system, along with possible predictors of New York Heart Association (NYHA) class I at 30 days and at 1 year.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!